Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

BACKGROUND: Detection of minimal residual disease (MRD) in the early phase of therapy is the most powerful predictor of relapse risk in children with acute lymphoblastic leukaemia (ALL). AIM: We aimed to determine the significance of MRD at the end of remission induction therapy in the prediction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovanovska, Aleksandra, Martinova, Kata, Kocheva, Svetlana, Trajkova-Antevska, Zorica, Coneska-Jovanova, Biljana, Panovska-Stavridis, Irina, Stankovikj, Svetlana, Trajkova, Sanja, Dimovski, Aleksandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901875/
https://www.ncbi.nlm.nih.gov/pubmed/31844443
http://dx.doi.org/10.3889/oamjms.2019.752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901875/
https://www.ncbi.nlm.nih.gov/pubmed/31844443
http://dx.doi.org/10.3889/oamjms.2019.752

Ejemplares similares